2017

Investigation of the Role of PIM 2 Kinase Inhibition via JP11646 for the Treatment of Acute Myeloid Leukemia

Visit USCO

Text Registration

Investigation of the Role of PIM 2 Kinase Inhibition via JP11646 for the Treatment of Acute Myeloid Leukemia

Status

Published

on 29 Dec 2017

Year of Creation

2017

Krista E. Belko

Registration Number

TX0008537819

on 29 Dec 2017

The U.S. Copyright record (Registration Number: TX0008537819) dated 29 Dec 2017, pertains to an electronic file (eService) titled "Investigation of the Role of PIM 2 Kinase Inhibition via JP11646 for the Treatment of Acute Myeloid Leukemia" created in 2017. The copyright holder is Krista E. Belko, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Krista E. Belko.

Krista E. Belko

Application Details

Registration Number

TX0008537819

Registration Date

12/29/2017

Year of Creation

2017

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Krista E Belko

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Investigation of the Role of PIM 2 Kinase Inhibition via JP11646 for the Treatment of Acute Myeloid Leukemia

Author Statement: Krista E. Belko Citizenship: United States Authorship: text

Notes

Rights Note: Mark Dill, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Investigation of the Role of PIM 2 Kinase Inhibition via JP11646 for the Treatment of Acute Myeloid Leukemia

Author Statement: Krista E. Belko Citizenship: United States Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.